• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 27 of 100
The politics behind President Biden’s plan to lower prescription drug prices
PoliticsThe politics behind President Biden’s plan to lower prescription drug prices
By Geoff ColvinAugust 14, 2021
Pharmacies face extra audit burdens that threaten their existence
HealthPharmacies face extra audit burdens that threaten their existence
By Markian Hawryluk and Kaiser Health NewsAugust 6, 2021
Eli Lilly’s shares rises to highest since June as Alzheimer’s treatment nears final-stage trial
FinanceEli Lilly’s shares rises to highest since June as Alzheimer’s treatment nears final-stage trial
By Robert Langreth and BloombergAugust 3, 2021
Image of a predicted protein structure rom the malaria parasite
HealthIn giant leap for biology, DeepMind’s A.I. reveals secret building blocks of human life
By Jeremy KahnJuly 22, 2021
A picture of a protein shape.
TechDeepMind unveils how it solved a 50-year-old scientific challenge that could speed drug discovery
By Jeremy KahnJuly 15, 2021
Biogen aduhelm aducanumab Alzheimer's doctor disapproval
NewslettersThe never ending Biogen Alzheimer’s drug saga delivers yet another twist
By Sy MukherjeeJuly 8, 2021
Biogen aduhelm aducanumab Alzheimer's doctor disapproval
HealthBiogen makes a drastic move, as doctors refuse to prescribe its controversial Alzheimer’s drug
By Sy MukherjeeJuly 8, 2021
Cures for many rare diseases might already exist. Why aren’t we using them?
CommentaryCures for many rare diseases might already exist. Why aren’t we using them?
By Annette BakkerJuly 5, 2021
Glaxo reaches $2.2 billion deal with Alector to develop drug targeting Alzheimer’s, Parkinson’s
HealthGlaxo reaches $2.2 billion deal with Alector to develop drug targeting Alzheimer’s, Parkinson’s
By Suzi Ring and BloombergJuly 2, 2021
States step up push to regulate pharmacy drug brokers
HealthStates step up push to regulate pharmacy drug brokers
By Katheryn Houghton and Kaiser Health NewsJune 30, 2021
Want cheaper insulin? Try Walmart
Want cheaper insulin? Try Walmart
By Marco Quiroz-GutierrezJune 29, 2021
Intellia CRISPR gene editing stock science
HealthWe can now edit genes inside the body. That sent this biotech’s stock soaring
By Sy MukherjeeJune 28, 2021
COVID Delta Delta plus variants
NewslettersThe delta between the Delta variants
By Sy MukherjeeJune 24, 2021
Janet Woodcock, acting commissioner of the U.S. Food and Drug Administration (FDA), listens during a Senate Appropriations Subcommittee hearing in Washington, D.C., U.S., on Thursday, June 10, 2021. The hearing is titled "Fiscal Year 2022 Budget Request for the FDA." Photographer: Al Drago/Bloomberg via Getty Images
HealthPressure mounts on Biden to nominate permanent FDA head as dissatisfaction with agency grows
By Sy MukherjeeJune 22, 2021
A woman in an Allcyte lab coat looking at images of cancer cells on a screen.
TechBritish A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company
By Jeremy KahnJune 15, 2021
1...
  • 25
  • 26
  • 27
  • 28
  • 29
...100
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Real Estate
The 'affordability economy' has created a housing market nobody predicted: Prices collapsing in the Sun Belt, soaring in the Rust Beltplaceholder alt text
By Fortune EditorsApril 11, 2026
Future of Work
Palantir CEO says AI ‘will destroy’ humanities jobs but there will be ‘more than enough jobs’ for people with vocational trainingplaceholder alt text
By Fortune EditorsApril 11, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.